{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:04:25Z","timestamp":1780646665366,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Recently, recommendations on perioperative care have been published to optimize postoperative outcomes in preoperative patients with inflammatory bowel disease. This study evaluated the current use of preoperative screening and prehabilitation strategies (PS) prior to elective ileocolic resection (ICR) in patients with Crohn\u2019s disease (CD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with CD who underwent an elective ICR were identified from a Dutch prospective cohort study. Primary endpoint was to evaluate to what extent IBD-relevant PS were applied in patients with CD prior to ICR according to the current recommendations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 109 CD patients were included. Screening of nutritional status was performed in 56% of the patients and revealed malnutrition in 46% of these patients. Of the malnourished patients, 46% was referred to a dietitian. Active smoking and alcohol consumption were reported in 20% and 28%; none of these patients were referred for a cessation program. A preoperative anemia was diagnosed in 61%, and ferritin levels were assessed in 26% of these patients. Iron therapy was started in 25% of the patients with an iron deficiency anemia. Exposure to corticosteroids at time of ICR was reported in 29% and weaned off in 3%. Consultation of a dietitian, psychologist, and physiotherapist was reported in 36%, 7%, and 3%. Physical fitness was assessed in none of the patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PS are not routinely applied and not individually tailored in the preoperative setting prior to elective ICR in patients with CD. Prior to implementation, future research on the costs and effectiveness of PS on postoperative outcomes and quality of life is necessary.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00384-023-04537-z","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T12:01:48Z","timestamp":1697716908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preoperative screening and prehabilitation strategies prior to ileocolic resection in patients with Crohn\u2019s disease are not incorporated in routine care"],"prefix":"10.1007","volume":"38","author":[{"given":"Michiel Thomas Jan","family":"Bak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oddeke","family":"van Ruler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurents","family":"Stassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Ruiterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine Hubertina Catharina","family":"Arkenbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Johanna Elisabeth","family":"Campmans-Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico Leonard Ulrich","family":"van Meeteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart Chateau","family":"Bongers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00eblle","family":"Romberg-Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"van der Marel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hoentjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen Willem","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie Charlotte","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Dutch Initiative Crohn and Colitis (ICC) and Dutch Initiative on Crohn and Colitis \u2013 Surgery (ICC-S)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"4537_CR1","doi-asserted-by":"crossref","unstructured":"Tsai L et al (2021) Contemporary risk of surgery in patients with ulcerative colitis and Crohn\u2019s disease: a meta-analysis of population-based cohorts. Clin Gastroenterol Hepatol 19(10):2031\u20132045 e11","DOI":"10.1016\/j.cgh.2020.10.039"},{"issue":"3","key":"4537_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/SLA.0000000000003395","volume":"273","author":"EMJ Beelen","year":"2021","unstructured":"Beelen EMJ et al (2021) Decreasing trends in intestinal resection and re-resection in Crohn\u2019s disease: a nationwide cohort study. Ann Surg 273(3):557\u2013563","journal-title":"Ann Surg"},{"issue":"7","key":"4537_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.2174\/1389450118666170502142939","volume":"19","author":"J Menichetti","year":"2018","unstructured":"Menichetti J, Fiorino G, Vegni E (2018) Personalizing psychological treatment along the IBD journey: from diagnosis to surgery. Curr Drug Targets 19(7):722\u2013728","journal-title":"Curr Drug Targets"},{"issue":"2","key":"4537_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/SLA.0000000000002017","volume":"267","author":"A Brouquet","year":"2018","unstructured":"Brouquet A et al (2018) Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for ileocolonic crohn disease: results of a prospective nationwide cohort. Ann Surg 267(2):221\u2013228","journal-title":"Ann Surg"},{"issue":"3","key":"4537_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10350-006-0782-0","volume":"50","author":"A Alves","year":"2007","unstructured":"Alves A et al (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn\u2019s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50(3):331\u2013336","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4537_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1177\/2050640615600116","volume":"4","author":"T Yamamoto","year":"2016","unstructured":"Yamamoto T et al (2016) Risk factors for complications after ileocolonic resection for Crohn\u2019s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: a retrospective international multicentre study. United European Gastroenterol J 4(6):784\u2013793","journal-title":"United European Gastroenterol J"},{"issue":"2","key":"4537_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ajg.2016.541","volume":"112","author":"M Fumery","year":"2017","unstructured":"Fumery M et al (2017) Postoperative complications after ileocecal resection in Crohn\u2019s disease: a prospective study from the REMIND group. Am J Gastroenterol 112(2):337\u2013345","journal-title":"Am J Gastroenterol"},{"key":"4537_CR8","doi-asserted-by":"crossref","unstructured":"Bak MT, Ruiterkamp MF, van Ruler O, Campmans-Kuijpers MJ, Bongers BC, van Meeteren NL, van der Woude CJ, Stassen LP, de Vries AC (2022)\u00a0Prehabilitation prior to intestinal resection in Crohn\u2019s disease patients: an opinion review. World J Gastroenterol 28(22):2403\u20132416","DOI":"10.3748\/wjg.v28.i22.2403"},{"issue":"12","key":"4537_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/EJA.0000000000001030","volume":"36","author":"G Thomas","year":"2019","unstructured":"Thomas G et al (2019) Prehabilitation before major intra-abdominal cancer surgery: a systematic review of randomised controlled trials. Eur J Anaesthesiol 36(12):933\u2013945","journal-title":"Eur J Anaesthesiol"},{"issue":"12","key":"4537_CR10","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00384-017-2915-4","volume":"32","author":"MS Zangenberg","year":"2017","unstructured":"Zangenberg MS et al (2017) Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review. Int J Colorectal Dis 32(12):1663\u20131676","journal-title":"Int J Colorectal Dis"},{"issue":"10","key":"4537_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/PHM.0000000000001221","volume":"98","author":"SJ van Rooijen","year":"2019","unstructured":"van Rooijen SJ et al (2019) Making patients fit for surgery: introducing a four pillar multimodal prehabilitation program in colorectal cancer. Am J Phys Med Rehabil 98(10):888\u2013896","journal-title":"Am J Phys Med Rehabil"},{"key":"4537_CR12","doi-asserted-by":"crossref","unstructured":"Berkel AEM et al (2021) Effects of Community-based exercise prehabilitation for patients scheduled for colorectal surgery with high risk for postoperative complications: results of a randomized clinical trial. Ann Surg","DOI":"10.1097\/SLA.0000000000005474"},{"key":"4537_CR13","doi-asserted-by":"crossref","unstructured":"van Wijk L et al (2022) Improved preoperative aerobic fitness following a home-based bimodal prehabilitation programme in high-risk patients scheduled for liver or pancreatic resection. Br J Surg","DOI":"10.1093\/bjs\/znac230"},{"key":"4537_CR14","doi-asserted-by":"crossref","unstructured":"Bongers BC, Dejong CH, den Dulk M (2021)\u00a0Enhanced recovery after surgery programmes in older patients undergoing hepatopancreatobiliary surgery: what benefits might prehabilitation have? Eur J Surg Oncol 47(3 Pt A):551\u2013559","DOI":"10.1016\/j.ejso.2020.03.211"},{"key":"4537_CR15","doi-asserted-by":"crossref","unstructured":"Sebastian S et al (2022) ECCO topical review: roadmap to optimal peri-operative care in IBD. J Crohns Colitis","DOI":"10.1093\/ecco-jcc\/jjac129"},{"key":"4537_CR16","unstructured":"Arkenbosch JHC et al (2022) Prophylactic medication for the prevention of endoscopic recurrence in Crohn\u2019s disease: a prospective study based on clinical risk stratification. J Crohns Colitis"},{"issue":"1","key":"4537_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/SLA.0000000000002293","volume":"267","author":"A Barberan-Garcia","year":"2018","unstructured":"Barberan-Garcia A et al (2018) Personalised prehabilitation in high-risk patients undergoing elective major abdominal surgery: a randomized blinded controlled trial. Ann Surg 267(1):50\u201356","journal-title":"Ann Surg"},{"key":"4537_CR18","doi-asserted-by":"publisher","first-page":"10330","DOI":"10.3389\/ti.2022.10330","volume":"35","author":"WD Jetten","year":"2022","unstructured":"Jetten WD et al (2022) Physical effects, safety and feasibility of prehabilitation in patients awaiting orthotopic liver transplantation, a systematic review. Transpl Int 35:10330","journal-title":"Transpl Int"},{"issue":"2","key":"4537_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","volume":"14","author":"M Adamina","year":"2020","unstructured":"Adamina M et al (2020) ECCO guidelines on therapeutics in Crohn\u2019s disease: surgical treatment. J Crohns Colitis 14(2):155\u2013168","journal-title":"J Crohns Colitis"},{"issue":"Suppl 3","key":"4537_CR20","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA et al (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68(Suppl 3):s1\u2013s106","journal-title":"Gut"},{"issue":"4","key":"4537_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/ecco-jcc\/jjz160","volume":"14","author":"M Adamina","year":"2019","unstructured":"Adamina M et al (2019) Perioperative dietary therapy in inflammatory bowel disease. J Crohns Colitis 14(4):431\u2013444","journal-title":"J Crohns Colitis"},{"issue":"9","key":"4537_CR22","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/ecco-jcc\/jjac041","volume":"16","author":"NS Ding","year":"2022","unstructured":"Ding NS et al (2022) Systematic review: the impact and importance of body composition in inflammatory bowel disease. J Crohns Colitis 16(9):1475\u20131492","journal-title":"J Crohns Colitis"},{"issue":"9","key":"4537_CR23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/MEG.0000000000001162","volume":"30","author":"GT Brennan","year":"2018","unstructured":"Brennan GT et al (2018) Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn\u2019s disease patients: a meta-analysis. Eur J Gastroenterol Hepatol 30(9):997\u20131002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"4537_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/apt.13934","volume":"45","author":"N Heerasing","year":"2017","unstructured":"Heerasing N et al (2017) Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn\u2019s disease. Aliment Pharmacol Ther 45(5):660\u2013669","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"4537_CR25","first-page":"1","volume":"12","author":"WA Bemelman","year":"2018","unstructured":"Bemelman WA et al (2018) ECCO-ESCP consensus on surgery for Crohn\u2019s disease. J Crohns Colitis 12(1):1\u201316","journal-title":"J Crohns Colitis"},{"key":"4537_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106742","volume":"104","author":"N McCaffrey","year":"2022","unstructured":"McCaffrey N et al (2022) A systematic review of economic evaluations of preoperative smoking cessation for preventing surgical complications. Int J Surg 104:106742","journal-title":"Int J Surg"},{"key":"4537_CR27","doi-asserted-by":"crossref","unstructured":"Law CC et al (2020) Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database Syst Rev 10(10):CD013256","DOI":"10.1002\/14651858.CD013256"},{"issue":"1","key":"4537_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.gastro.2022.03.057","volume":"163","author":"BL Cohen","year":"2022","unstructured":"Cohen BL et al (2022) Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra-abdominal surgery. Gastroenterology 163(1):204\u2013221","journal-title":"Gastroenterology"},{"issue":"3","key":"4537_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/bjaceaccp\/mks064","volume":"13","author":"GA Hans","year":"2013","unstructured":"Hans GA, Jones N (2013) Preoperative anaemia. Continuing education in anaesthesia critical care & pain 13(3):71\u201374","journal-title":"Continuing Education in Anaesthesia Critical Care & Pain"},{"issue":"3","key":"4537_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","volume":"9","author":"AU Dignass","year":"2015","unstructured":"Dignass AU et al (2015) European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 9(3):211\u2013222","journal-title":"J Crohns Colitis"},{"issue":"11","key":"4537_CR31","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00384-012-1533-4","volume":"27","author":"JM Otto","year":"2012","unstructured":"Otto JM et al (2012) Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing. Int J Colorectal Dis 27(11):1485\u20131491","journal-title":"Int J Colorectal Dis"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04537-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-023-04537-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04537-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T11:38:34Z","timestamp":1703158714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-023-04537-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4537"],"URL":"https:\/\/doi.org\/10.1007\/s00384-023-04537-z","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"18 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michiel Thomas Jan Bak, Marit Ruiterkamp, Jeanine Hubertina Catharina Arkenbosch, Maria Johanna Elisabeth Campmans-Kuijpers, Nico Leonard Ulrich van Meeteren, Bart Chateau Bongers, Mari\u00eblle Romberg-Camps, Sander van der Marel en Koen Willem van Dongen have no disclosures. Oddeke van Ruler has served as invited speaker for Janssen-Cilag and has received non-financial support from Takeda outside the submitted work. Laurents Stassen has served as a speaker and received research support from Takeda, outside the submitted work. Gerard Dijkstra has received a grant from Royal DSM and speaker fees from: Abbvie, Janssen-Cilag, Takeda and Pfizer. Frank Hoentjen has served on advisory boards or as speaker for Abbvie, Janssen-Cilag, MSD, Takeda, Celltrion, Teva, Sandoz and Dr Falk, and has received funding (grants\/honoraria) from Dr Falk, Janssen-Cilag, Abbvie, Takeda and consulting fees from Celgene and Janssen-Cilag, all outside the submitted work. Rachel West has served on the advisory board and as invited speaker for Janssen, Pfizer, Takeda and Galapagos outside the submitted work. Janneke van der Woude received grants and or fee for advisory boards and presentations from Pfizer, Abbvie, Celltrion, Falk Benelux, Takeda, Janssen and Ferring outside the submitted work. Annemarie Charlotte de Vries has served on advisory boards for Takeda, Janssen, Bristol Myers Squibb, Abbvie, Pfizer, and Galapagos and has received unrestricted research grants from Takeda, Janssen, and Pfizer outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"254"}}